Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW685698X Nasal Spray 100 mcg Once Daily in Perennial Allergic Rhinitis
2005-004493-25Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in perennial rhinitis (2 arms), sponsored by GSK. Primary endpoint: Mean change from baseline in reflective total nasal symptom score (rTNSS). Started Dec 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2005-004493-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004493-25.